MedAdvisor (ASX:MDR) secured approval from the Federal Court of Australia on Friday to rectify a late cleansing notice tied to its share placement, according to a Friday filing with the Australian bourse.
The company sought court orders after missing the deadline to submit a cleansing notice for 45.8 million shares issued on April 8 under a placement, due to an administrative oversight, the filing said.
The company has requested the immediate lifting of its voluntary trading suspension, which has been in place since April 29, the filing added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.